Proactiveinvestors United Kingdom RNS press releases https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom RNS press releases RSS feed en Sun, 26 May 2019 10:09:38 +0100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - AGM Statement ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190522135003_14083870 Wed, 22 May 2019 13:50:03 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190522135003_14083870 <![CDATA[RNS press release - Orphan Disease Opportunity for Iclaprim ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190522070006_14082732 Wed, 22 May 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190522070006_14082732 <![CDATA[RNS press release - Iclaprim Data presented at ASM Microbe 2019 ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190521070025_14081007 Tue, 21 May 2019 07:00:25 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190521070025_14081007 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190520181422_14080784 Mon, 20 May 2019 18:14:22 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190520181422_14080784 <![CDATA[RNS press release - Meeting with US FDA held as planned ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190503182503_14063296 Fri, 03 May 2019 18:25:03 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190503182503_14063296 <![CDATA[RNS press release - Motif Signs Agreement with Lamellar Biomedical ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190501070014_14058482 Wed, 01 May 2019 07:00:14 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190501070014_14058482 <![CDATA[RNS press release - Notice of AGM ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190426070103_14052824 Fri, 26 Apr 2019 07:01:03 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190426070103_14052824 <![CDATA[RNS press release - Appointment of Andrew Powell to Board of Directors ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190426070011_14052781 Fri, 26 Apr 2019 07:00:11 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190426070011_14052781 <![CDATA[RNS press release - Motif Presents New Iclaprim Data at ECCMID 2019 ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190416070015_14042103 Tue, 16 Apr 2019 07:00:15 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190416070015_14042103 <![CDATA[RNS press release - Fiscal Year 2018 Results ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190415070007_14040326 Mon, 15 Apr 2019 07:00:07 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190415070007_14040326 <![CDATA[RNS press release - Motif Bio to Present Iclaprim Data at ECCMID 2019 ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190404070013_14028240 Thu, 04 Apr 2019 07:00:13 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190404070013_14028240 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190402174355_14026227 Tue, 02 Apr 2019 17:43:55 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190402174355_14026227 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190401152807_14024074 Mon, 01 Apr 2019 15:28:07 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190401152807_14024074 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190401141735_14023907 Mon, 01 Apr 2019 14:17:35 +0100 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190401141735_14023907 <![CDATA[RNS press release - Motif Bio Raises £2.7m (US$3.55m) ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190326070017_14015167 Tue, 26 Mar 2019 07:00:17 +0000 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190326070017_14015167 <![CDATA[RNS press release - Proposed Equity Fundraise ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190325094953_14014125 Mon, 25 Mar 2019 09:49:53 +0000 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190325094953_14014125 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190320070010_14008316 Wed, 20 Mar 2019 07:00:10 +0000 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190320070010_14008316 <![CDATA[RNS press release - Motif Bio Granted Meeting with U.S. FDA ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190320070006_14008292 Wed, 20 Mar 2019 07:00:06 +0000 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190320070006_14008292 <![CDATA[RNS press release - Appointment of Bruce Williams as Interim Chairman ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190318070007_14005028 Mon, 18 Mar 2019 07:00:07 +0000 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190318070007_14005028 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190315070105_14003292 Fri, 15 Mar 2019 07:01:05 +0000 https://www.proactiveinvestors.co.uk/LON:MTFB/Motif-Bio-PLC/rns/LSE20190315070105_14003292